Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Receivables (2016 - 2026)

Collegium Pharmaceutical has reported Change in Receivables over the past 10 years, most recently at -$22.6 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 21240.57% year-over-year to -$22.6 million; the TTM value through Dec 2025 reached -$17.2 million, down 489.76%, while the annual FY2025 figure was -$17.2 million, 489.76% down from the prior year.
  • Change in Receivables for Q4 2025 was -$22.6 million at Collegium Pharmaceutical, down from $20.9 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $58.9 million in Q3 2021 and troughed at -$43.2 million in Q4 2021.
  • A 5-year average of $1.4 million and a median of -$1.1 million in 2022 define the central range for Change in Receivables.
  • On a YoY basis, Change in Receivables climbed as much as 10913.68% in 2025 and fell as far as 21240.57% in 2025.
  • Year by year, Change in Receivables stood at -$43.2 million in 2021, then skyrocketed by 71.54% to -$12.3 million in 2022, then soared by 81.06% to -$2.3 million in 2023, then surged by 95.44% to -$106000.0 in 2024, then tumbled by 21240.57% to -$22.6 million in 2025.
  • Business Quant data shows Change in Receivables for COLL at -$22.6 million in Q4 2025, $20.9 million in Q3 2025, and -$15.7 million in Q2 2025.